SEQUUS PHARMACEUTICALS
More informations about "SEQUUS Pharmaceuticals"
SEQUUS Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Nov 1, 2024 Explore SEQUUS Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 1 news, and 35 literature, Drug:Doxorubicin …See details»
SEQUUS Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. SEQUUS Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Alternatives and possible …See details»
SEQUUS Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical …
Jun 12, 2023 Explore SEQUUS Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, and 29 literature.See details»
Sequus Pharmaceuticals Inc - Company Profile and News
Company profile page for Sequus Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Sequus Pharmaceuticals - Products, Competitors, Financials, …
Manufacturer of pharmaceutical products to treat cancer and infectious diseases. The company develops, manufactures, and markets a range of pharmaceutical products to treat cancer and …See details»
SEQUUS Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. SEQUUS Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
SEQUUS Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. SEQUUS Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Mindspace: The Beginning. The story behind …
Feb 23, 2019 Running a $50,000 program bumped Mindspace to the next level as a non-profit organization. Todd Pierce (left) — Paul Kidner (center) — Mike Snyder (right) all spoke at FuckUp Nights events ...See details»
Sequus Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Sequus Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Alza acquisition to bolster position in cancer market - SFGATE
Oct 6, 1998 PALO ALTO - Alza Corp. said Monday it will buy Sequus Pharmaceuticals Inc. for $580 million in stock in a move to bolster its commercial drug development, especially in areas …See details»
SEQUUS RAISES $43M IN OVERSUBSCRIBED OFFERING
Oct 26, 1995 Sequus Pharmaceuticals Inc., awaiting word to market itsfirst product in the U.S., grossed about $43 million in anoversubscribed public offering of 3.9 million shares at$11 …See details»
Alza Boosts Oncology With $580M Sequus Acquisition
Oct 5, 1998 California, USA-based companies Alza Corp and Sequus Pharmaceuticalshave entered into a definitive merger agreement, whereby Alza will acquire Sequus in a stock-for …See details»
Alza Buying Sequus for $580 Million / Valuable cancer products
Oct 6, 1998 Alza Corp. said yesterday it will buy Bay Area neighbor Sequus Pharmaceuticals in a $580 million stock-swap deal intended to speed the development and deployment of …See details»
Alza To Acquire Sequus Through Stock Swap Valued at $580 Mil.
Oct 12, 1998 The sales force for Doxil will triple with the Alza acquisition of Sequus announced Oct. 5. The Doxil sales force will increase from Sequus' current 30 reps devoted to the product …See details»
Proof of concept for next-generation nanoparticle drugs in …
Jun 7, 2012 Scott Minick, former president of Sequus Pharmaceuticals (now part of J&J), the original developer of Doxil, recalls that when the drug was first approved, around one batch in …See details»
SEQUUS Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Explore SEQUUS Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, and 29 literature, Drug:SPI-40, SPI-119.See details»
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial …
1 day ago CHATHAM, N.J., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical …See details»
Efficacy of pegylated-liposomal doxorubicin in the treatment
Patients received 20 mg/m2 pegylated-liposomal doxorubicin (Doxil; Sequus Pharmaceuticals, Inc, Menlo Park, CA) every 3 weeks. Results: Nineteen patients (36%) had a partial response …See details»
Sequus Gets First Approval For Doxil - Pharmaceutical industry …
Nov 27, 1995 Sequus Gets First Approval For Doxil. sequus, gets, first, approval, doxil, pharmaceuticals, been. ... Sequus Pharmaceuticals has been granted approval by the US …See details»
Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): …
Sixteen patients who were continued on caelyx/doxil (Sequus Pharmaceuticals Inc., Menlo Park, CA) for >1 year were identified by June 2004, and the results were updated to July 2006. ...See details»